
Beneficient (NASDAQ:BENF – Free Report) – Sidoti increased their Q2 2027 EPS estimates for Beneficient in a research note issued to investors on Thursday, September 10th. Sidoti analyst B. Mccarthy now expects that the company will post earnings of ($0.62) per share for the quarter, up from their previous forecast of ($1.14). The consensus estimate for Beneficient’s current full-year earnings is ($9.50) per share. Sidoti also issued estimates for Beneficient’s Q3 2027 earnings at ($0.35) EPS, Q4 2027 earnings at ($0.15) EPS and FY2027 earnings at ($9.50) EPS.
Beneficient (NASDAQ:BENF – Get Free Report) last posted its quarterly earnings results on Friday, August 14th. The company reported ($0.47) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.06) by $1.59. The business had revenue of $15.93 million during the quarter, compared to the consensus estimate of $10.16 million.
Check Out Our Latest Research Report on BENF
Beneficient Stock Performance
NASDAQ:BENF opened at $0.60 on Monday. Beneficient has a 1 year low of $0.57 and a 1 year high of $12.48. The business has a fifty day moving average of $2.60 and a 200-day moving average of $3.23. The stock has a market cap of $8.74 million, a price-to-earnings ratio of -0.08 and a beta of -0.04.
Beneficient Company Profile
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. The company offers Ben AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks, and complete their transactions with standardized transaction agreements.
See Also
- Five stocks we like better than Beneficient
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
